Clinical Trial Update: Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating radioimmunoguided intensity-modulated radiotherapy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Radioimmunoguided IMRT

Snippet

Sponsor: Mayo Clinic | Conditions: Prostatic Neoplasm | Phase 1, Phase 2 | Status: COMPLETED